Global Monoclonal Antibody Therapeutics Market Size, Status and Forecast 2025

June 2018 | 97 pages | ID: G9D3CB0ED50EN
QYResearch

Abstracts

This report studies the global Monoclonal Antibody Therapeutics market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Monoclonal Antibody Therapeutics market by companies, region, type and end-use industry.
In 2017, the global Monoclonal Antibody Therapeutics market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025.

This report focuses on the global top players, covered

• Bayer
• F. Hoffmann-La Roche
• Pfizer
• Sanofi
• GlaxoSmithKline
• Merck
• Novartis
• AbbVie
• Amgen
• Johnson & Johnson
• Bristol-Myers Squibb Company
• Biogen

Market segment by Regions/Countries, this report covers

• United States
• Europe
• China
• Japan
• Southeast Asia
• India

Market segment by Type, the product can be split into

• Humanized Antibody
• Human Mouse Chimeric Antibody

Market segment by Application, split into

• Cancer
• Autoimmune Diseases
• Infection
• Hematological Diseases
• Ophthalmological Diseases
• Others

The study objectives of this report are:

• To study and forecast the market size of Monoclonal Antibody Therapeutics in global market.
• To analyze the global key players, SWOT analysis, value and global market share for top players.
• To define, describe and forecast the market by type, end use and region.
• To analyze and compare the market status and forecast between China and major regions, namely, United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
• To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks.
• To identify significant trends and factors driving or inhibiting the market growth.
• To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
• To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
• To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Monoclonal Antibody Therapeutics are as follows:

• History Year: 2013-2017
• Base Year: 2017
• Estimated Year: 2018
• Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Monoclonal Antibody Therapeutics Manufacturers
Monoclonal Antibody Therapeutics Distributors/Traders/Wholesalers
Monoclonal Antibody Therapeutics Subcomponent Manufacturers
Industry Association
Downstream Vendors
Available Customizations

With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Monoclonal Antibody Therapeutics market, by end-use.
Detailed analysis and profiles of additional market players.

Contents

Global Monoclonal Antibody Therapeutics Market Size, Status and Forecast 2025

1 INDUSTRY OVERVIEW OF MONOCLONAL ANTIBODY THERAPEUTICS

1.1 Monoclonal Antibody Therapeutics Market Overview
  1.1.1 Monoclonal Antibody Therapeutics Product Scope
  1.1.2 Market Status and Outlook
1.2 Global Monoclonal Antibody Therapeutics Market Size and Analysis by Regions (2013-2018)
  1.2.1 United States
  1.2.2 Europe
  1.2.3 China
  1.2.4 Japan
  1.2.5 Southeast Asia
  1.2.6 India
1.3 Monoclonal Antibody Therapeutics Market by Type
  1.3.1 Humanized Antibody
  1.3.2 Human Mouse Chimeric Antibody
1.4 Monoclonal Antibody Therapeutics Market by End Users/Application
  1.4.1 Cancer
  1.4.2 Autoimmune Diseases
  1.4.3 Infection
  1.4.4 Hematological Diseases
  1.4.5 Ophthalmological Diseases
  1.4.6 Others

2 GLOBAL MONOCLONAL ANTIBODY THERAPEUTICS COMPETITION ANALYSIS BY PLAYERS

2.1 Monoclonal Antibody Therapeutics Market Size (Value) by Players (2013-2018)
2.2 Competitive Status and Trend
  2.2.1 Market Concentration Rate
  2.2.2 Product/Service Differences
  2.2.3 New Entrants
  2.2.4 The Technology Trends in Future

3 COMPANY (TOP PLAYERS) PROFILES

3.1 Bayer
  3.1.1 Company Profile
  3.1.2 Main Business/Business Overview
  3.1.3 Products, Services and Solutions
  3.1.4 Monoclonal Antibody Therapeutics Revenue (Million USD) (2013-2018)
3.2 F. Hoffmann-La Roche
  3.2.1 Company Profile
  3.2.2 Main Business/Business Overview
  3.2.3 Products, Services and Solutions
  3.2.4 Monoclonal Antibody Therapeutics Revenue (Million USD) (2013-2018)
3.3 Pfizer
  3.3.1 Company Profile
  3.3.2 Main Business/Business Overview
  3.3.3 Products, Services and Solutions
  3.3.4 Monoclonal Antibody Therapeutics Revenue (Million USD) (2013-2018)
3.4 Sanofi
  3.4.1 Company Profile
  3.4.2 Main Business/Business Overview
  3.4.3 Products, Services and Solutions
  3.4.4 Monoclonal Antibody Therapeutics Revenue (Million USD) (2013-2018)
3.5 GlaxoSmithKline
  3.5.1 Company Profile
  3.5.2 Main Business/Business Overview
  3.5.3 Products, Services and Solutions
  3.5.4 Monoclonal Antibody Therapeutics Revenue (Million USD) (2013-2018)
3.6 Merck
  3.6.1 Company Profile
  3.6.2 Main Business/Business Overview
  3.6.3 Products, Services and Solutions
  3.6.4 Monoclonal Antibody Therapeutics Revenue (Million USD) (2013-2018)
3.7 Novartis
  3.7.1 Company Profile
  3.7.2 Main Business/Business Overview
  3.7.3 Products, Services and Solutions
  3.7.4 Monoclonal Antibody Therapeutics Revenue (Million USD) (2013-2018)
3.8 AbbVie
  3.8.1 Company Profile
  3.8.2 Main Business/Business Overview
  3.8.3 Products, Services and Solutions
  3.8.4 Monoclonal Antibody Therapeutics Revenue (Million USD) (2013-2018)
3.9 Amgen
  3.9.1 Company Profile
  3.9.2 Main Business/Business Overview
  3.9.3 Products, Services and Solutions
  3.9.4 Monoclonal Antibody Therapeutics Revenue (Million USD) (2013-2018)
3.10 Johnson & Johnson
  3.10.1 Company Profile
  3.10.2 Main Business/Business Overview
  3.10.3 Products, Services and Solutions
  3.10.4 Monoclonal Antibody Therapeutics Revenue (Million USD) (2013-2018)
3.11 Bristol-Myers Squibb Company
3.12 Biogen

4 GLOBAL MONOCLONAL ANTIBODY THERAPEUTICS MARKET SIZE BY TYPE AND APPLICATION (2013-2018)

4.1 Global Monoclonal Antibody Therapeutics Market Size by Type (2013-2018)
4.2 Global Monoclonal Antibody Therapeutics Market Size by Application (2013-2018)
4.3 Potential Application of Monoclonal Antibody Therapeutics in Future
4.4 Top Consumer/End Users of Monoclonal Antibody Therapeutics

5 UNITED STATES MONOCLONAL ANTIBODY THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK

5.1 United States Monoclonal Antibody Therapeutics Market Size (2013-2018)
5.2 United States Monoclonal Antibody Therapeutics Market Size and Market Share by Players (2013-2018)
5.3 United States Monoclonal Antibody Therapeutics Market Size by Application (2013-2018)

6 EUROPE MONOCLONAL ANTIBODY THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK

6.1 Europe Monoclonal Antibody Therapeutics Market Size (2013-2018)
6.2 Europe Monoclonal Antibody Therapeutics Market Size and Market Share by Players (2013-2018)
6.3 Europe Monoclonal Antibody Therapeutics Market Size by Application (2013-2018)

7 CHINA MONOCLONAL ANTIBODY THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK

7.1 China Monoclonal Antibody Therapeutics Market Size (2013-2018)
7.2 China Monoclonal Antibody Therapeutics Market Size and Market Share by Players (2013-2018)
7.3 China Monoclonal Antibody Therapeutics Market Size by Application (2013-2018)

8 JAPAN MONOCLONAL ANTIBODY THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK

8.1 Japan Monoclonal Antibody Therapeutics Market Size (2013-2018)
8.2 Japan Monoclonal Antibody Therapeutics Market Size and Market Share by Players (2013-2018)
8.3 Japan Monoclonal Antibody Therapeutics Market Size by Application (2013-2018)

9 SOUTHEAST ASIA MONOCLONAL ANTIBODY THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK

9.1 Southeast Asia Monoclonal Antibody Therapeutics Market Size (2013-2018)
9.2 Southeast Asia Monoclonal Antibody Therapeutics Market Size and Market Share by Players (2013-2018)
9.3 Southeast Asia Monoclonal Antibody Therapeutics Market Size by Application (2013-2018)

10 INDIA MONOCLONAL ANTIBODY THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK

10.1 India Monoclonal Antibody Therapeutics Market Size (2013-2018)
10.2 India Monoclonal Antibody Therapeutics Market Size and Market Share by Players (2013-2018)
10.3 India Monoclonal Antibody Therapeutics Market Size by Application (2013-2018)

11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2018-2025)

11.1 Global Monoclonal Antibody Therapeutics Market Size (Value) by Regions (2018-2025)
  11.1.1 United States Monoclonal Antibody Therapeutics Revenue and Growth Rate (2018-2025)
  11.1.2 Europe Monoclonal Antibody Therapeutics Revenue and Growth Rate (2018-2025)
  11.1.3 China Monoclonal Antibody Therapeutics Revenue and Growth Rate (2018-2025)
  11.1.4 Japan Monoclonal Antibody Therapeutics Revenue and Growth Rate (2018-2025)
  11.1.5 Southeast Asia Monoclonal Antibody Therapeutics Revenue and Growth Rate (2018-2025)
  11.1.6 India Monoclonal Antibody Therapeutics Revenue and Growth Rate (2018-2025)
11.2 Global Monoclonal Antibody Therapeutics Market Size (Value) by Type (2018-2025)
11.3 Global Monoclonal Antibody Therapeutics Market Size by Application (2018-2025)

12 MONOCLONAL ANTIBODY THERAPEUTICS MARKET DYNAMICS

12.1 Monoclonal Antibody Therapeutics Market Opportunities
12.2 Monoclonal Antibody Therapeutics Challenge and Risk
  12.2.1 Competition from Opponents
  12.2.2 Downside Risks of Economy
12.3 Monoclonal Antibody Therapeutics Market Constraints and Threat
  12.3.1 Threat from Substitute
  12.3.2 Government Policy
  12.3.3 Technology Risks
12.4 Monoclonal Antibody Therapeutics Market Driving Force
  12.4.1 Growing Demand from Emerging Markets
  12.4.2 Potential Application

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
  13.3.1 Economic Fluctuations
  13.3.2 Other Risk Factors

14 RESEARCH FINDING/CONCLUSION

15 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Global Monoclonal Antibody Therapeutics Market Size (Million USD) Status and Outlook (2013-2018)
Table Global Monoclonal Antibody Therapeutics Revenue (Million USD) Comparison by Regions (2013-2018)
Figure Global Monoclonal Antibody Therapeutics Market Share by Regions (2013-2018)
Figure United States Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Europe Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure China Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Japan Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Southeast Asia Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure India Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Table Global Monoclonal Antibody Therapeutics Revenue (Million USD) and Growth Rate (%) Comparison by Product (2013-2018)
Figure Global Monoclonal Antibody Therapeutics Revenue Market Share by Type in 2017
Figure Humanized Antibody Market Size (Million USD) and Growth Rate (2013-2018)
Figure Human Mouse Chimeric Antibody Market Size (Million USD) and Growth Rate (2013-2018)
Figure Global Monoclonal Antibody Therapeutics Market Share by Application in 2017
Figure Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate in Cancer (2013-2018)
Figure Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate in Autoimmune Diseases (2013-2018)
Figure Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate in Infection (2013-2018)
Figure Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate in Hematological Diseases (2013-2018)
Figure Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate in Ophthalmological Diseases (2013-2018)
Figure Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate in Others (2013-2018)
Table Monoclonal Antibody Therapeutics Market Size (Million USD) by Players (2013-2018)
Figure Monoclonal Antibody Therapeutics Market Size Share by Players in 2013
Figure Monoclonal Antibody Therapeutics Market Size Share by Players in 2017
Table Bayer Basic Information List
Table Monoclonal Antibody Therapeutics Business Revenue (Million USD) of Bayer (2013-2018)
Figure Bayer Monoclonal Antibody Therapeutics Business Revenue Market Share (2013-2018)
Table F. Hoffmann-La Roche Basic Information List
Table Monoclonal Antibody Therapeutics Business Revenue (Million USD) of F. Hoffmann-La Roche (2013-2018)
Figure F. Hoffmann-La Roche Monoclonal Antibody Therapeutics Business Revenue Market Share (2013-2018)
Table Pfizer Basic Information List
Table Monoclonal Antibody Therapeutics Business Revenue (Million USD) of Pfizer (2013-2018)
Figure Pfizer Monoclonal Antibody Therapeutics Business Revenue Market Share (2013-2018)
Table Sanofi Basic Information List
Table Monoclonal Antibody Therapeutics Business Revenue (Million USD) of Sanofi (2013-2018)
Figure Sanofi Monoclonal Antibody Therapeutics Business Revenue Market Share (2013-2018)
Table GlaxoSmithKline Basic Information List
Table Monoclonal Antibody Therapeutics Business Revenue (Million USD) of GlaxoSmithKline (2013-2018)
Figure GlaxoSmithKline Monoclonal Antibody Therapeutics Business Revenue Market Share (2013-2018)
Table Merck Basic Information List
Table Monoclonal Antibody Therapeutics Business Revenue (Million USD) of Merck (2013-2018)
Figure Merck Monoclonal Antibody Therapeutics Business Revenue Market Share (2013-2018)
Table Novartis Basic Information List
Table Monoclonal Antibody Therapeutics Business Revenue (Million USD) of Novartis (2013-2018)
Figure Novartis Monoclonal Antibody Therapeutics Business Revenue Market Share (2013-2018)
Table AbbVie Basic Information List
Table Monoclonal Antibody Therapeutics Business Revenue (Million USD) of AbbVie (2013-2018)
Figure AbbVie Monoclonal Antibody Therapeutics Business Revenue Market Share (2013-2018)
Table Amgen Basic Information List
Table Monoclonal Antibody Therapeutics Business Revenue (Million USD) of Amgen (2013-2018)
Figure Amgen Monoclonal Antibody Therapeutics Business Revenue Market Share (2013-2018)
Table Johnson & Johnson Basic Information List
Table Monoclonal Antibody Therapeutics Business Revenue (Million USD) of Johnson & Johnson (2013-2018)
Figure Johnson & Johnson Monoclonal Antibody Therapeutics Business Revenue Market Share (2013-2018)
Table Bristol-Myers Squibb Company Basic Information List
Table Monoclonal Antibody Therapeutics Business Revenue (Million USD) of Bristol-Myers Squibb Company (2013-2018)
Figure Bristol-Myers Squibb Company Monoclonal Antibody Therapeutics Business Revenue Market Share (2013-2018)
Table Biogen Basic Information List
Table Monoclonal Antibody Therapeutics Business Revenue (Million USD) of Biogen (2013-2018)
Figure Biogen Monoclonal Antibody Therapeutics Business Revenue Market Share (2013-2018)
Table Global Monoclonal Antibody Therapeutics Market Size (Million USD) by Product (2013-2018)
Figure Global Monoclonal Antibody Therapeutics Revenue Market Share (%) by Product (2013-2018)
Figure Global Monoclonal Antibody Therapeutics Market Share by Product in 2017
Table Global Monoclonal Antibody Therapeutics Market Size by Application (2013-2018)
Figure Global Monoclonal Antibody Therapeutics Revenue Market Share (%) by Application in 2017
Table Top Consumer/End Users of Monoclonal Antibody Therapeutics
Figure United States Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate (2013-2018)
Table United States Monoclonal Antibody Therapeutics Market Size (Million USD) by Players (2013-2018)
Figure United States Monoclonal Antibody Therapeutics Market Size Share by Players in 2013
Figure United States Monoclonal Antibody Therapeutics Market Size Share by Players in 2017
Table United States Monoclonal Antibody Therapeutics Market Size by Application (2013-2018)
Figure United States Monoclonal Antibody Therapeutics Revenue Market Share (%) by Application (2013-2018)
Figure United States Monoclonal Antibody Therapeutics Market Size Share by Application in 2017
Figure Europe Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate (2013-2018)
Table Europe Monoclonal Antibody Therapeutics Market Size (Million USD) by Players (2013-2018)
Figure Europe Monoclonal Antibody Therapeutics Market Size Share by Players in 2013
Figure Europe Monoclonal Antibody Therapeutics Market Size Share by Players in 2017
Table Europe Monoclonal Antibody Therapeutics Market Size by Application (2013-2018)
Figure Europe Monoclonal Antibody Therapeutics Revenue Market Share (%) by Application (2013-2018)
Figure Europe Monoclonal Antibody Therapeutics Market Size Share by Application in 2017
Figure China Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate (2013-2018)
Table China Monoclonal Antibody Therapeutics Market Size (Million USD) by Players (2013-2018)
Figure China Monoclonal Antibody Therapeutics Market Size Share by Players in 2013
Figure China Monoclonal Antibody Therapeutics Market Size Share by Players in 2017
Table China Monoclonal Antibody Therapeutics Market Size by Application (2013-2018)
Figure China Monoclonal Antibody Therapeutics Revenue Market Share (%) by Application (2013-2018)
Figure China Monoclonal Antibody Therapeutics Market Size Share by Application in 2017
Figure Japan Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate (2013-2018)
Table Japan Monoclonal Antibody Therapeutics Market Size (Million USD) by Players (2013-2018)
Figure Japan Monoclonal Antibody Therapeutics Market Size Share by Players in 2013
Figure Japan Monoclonal Antibody Therapeutics Market Size Share by Players in 2017
Table Japan Monoclonal Antibody Therapeutics Market Size by Application (2013-2018)
Figure Japan Monoclonal Antibody Therapeutics Revenue Market Share (%) by Application (2013-2018)
Figure Japan Monoclonal Antibody Therapeutics Market Size Share by Application in 2017
Figure Southeast Asia Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate (2013-2018)
Table Southeast Asia Monoclonal Antibody Therapeutics Market Size (Million USD) by Players (2013-2018)
Figure Southeast Asia Monoclonal Antibody Therapeutics Market Size Share by Players in 2013
Figure Southeast Asia Monoclonal Antibody Therapeutics Market Size Share by Players in 2017
Table Southeast Asia Monoclonal Antibody Therapeutics Market Size by Application (2013-2018)
Figure Southeast Asia Monoclonal Antibody Therapeutics Revenue Market Share (%) by Application (2013-2018)
Figure Southeast Asia Monoclonal Antibody Therapeutics Market Size Share by Application in 2017
Figure India Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate (2013-2018)
Table India Monoclonal Antibody Therapeutics Market Size (Million USD) by Players (2013-2018)
Figure India Monoclonal Antibody Therapeutics Market Size Share by Players in 2013
Figure India Monoclonal Antibody Therapeutics Market Size Share by Players in 2017
Table India Monoclonal Antibody Therapeutics Market Size by Application (2013-2018)
Figure India Monoclonal Antibody Therapeutics Revenue Market Share (%) by Application (2013-2018)
Figure India Monoclonal Antibody Therapeutics Market Size Share by Application in 2017
Figure Global Monoclonal Antibody Therapeutics Market Size and Growth Rate (2018-2025)
Table Global Monoclonal Antibody Therapeutics Market Size (Million USD) by Regions (2018-2025)
Figure Global Monoclonal Antibody Therapeutics Market Size Share (2018-2025)
Figure Global Monoclonal Antibody Therapeutics Market Size Share by Regions in 2025
Figure United States Monoclonal Antibody Therapeutics Revenue (Million USD) and Growth Rate (2018-2025)
Figure Europe Monoclonal Antibody Therapeutics Revenue (Million USD) and Growth Rate (2018-2025)
Figure China Monoclonal Antibody Therapeutics Revenue (Million USD) and Growth Rate (2018-2025)
Figure Japan Monoclonal Antibody Therapeutics Revenue (Million USD) and Growth Rate (2018-2025)
Figure Southeast Asia Monoclonal Antibody Therapeutics Revenue (Million USD) and Growth Rate (2018-2025)
Figure India Monoclonal Antibody Therapeutics Revenue (Million USD) and Growth Rate (2018-2025)
Table Global Monoclonal Antibody Therapeutics Market Size (Million USD) by Type (2018-2025)
Figure Global Monoclonal Antibody Therapeutics Market Size Share by Type in 2018
Figure Global Monoclonal Antibody Therapeutics Market Size Share by Type in 2025
Table Global Monoclonal Antibody Therapeutics Market Size (Million USD) by Application (2018-2025)
Figure Global Monoclonal Antibody Therapeutics Market Size (Million USD) by Application in 2018